Pretax income is the income that a company earns before paying income taxes. Achieve Life Sciences's pretax income for the
three
months ended in Sep. 2024 was $-12.51 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was $-32.94 Mil.
Achieve Life Sciences's pretax margin was %.
During the past 13 years, Achieve Life Sciences's highest Pretax Margin was -92.52%. The lowest was -96.77%. And the median was -94.65%.
Achieve Life Sciences Pre-Tax Income Historical Data
The historical data trend for Achieve Life Sciences's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Achieve Life Sciences's Pre-Tax Income
For the Biotechnology subindustry, Achieve Life Sciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Achieve Life Sciences's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Achieve Life Sciences's Pre-Tax Income falls into.
Achieve Life Sciences Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Achieve Life Sciences's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-32.94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Achieve Life Sciences (NAS:ACHV) Pre-Tax Income Explanation
Achieve Life Sciences's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as
During the past 13 years, Achieve Life Sciences's highest Pretax Margin was -92.52%. The lowest was -96.77%. And the median was -94.65%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Achieve Life Sciences Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Achieve Life Sciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ACHV has been successfully added to your 